THETIS PHARMACEUTICALS LLC has a total of 60 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and foods and drinks are PRONOVA BIOPHARMA NORGE AS, HOLMEIDE ANNE KRISTIN and GARBIL PHARMA INVESTIGACION CH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 15 | |
#2 | WIPO (World Intellectual Property Organization) | 10 | |
#3 | EPO (European Patent Office) | 7 | |
#4 | Canada | 6 | |
#5 | China | 5 | |
#6 | Australia | 4 | |
#7 | Israel | 3 | |
#8 | Republic of Korea | 3 | |
#9 | Mexico | 3 | |
#10 | Brazil | 2 | |
#11 | India | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Foods and drinks | |
#4 | Biotechnology | |
#5 | Basic materials chemistry | |
#6 | Macromolecular chemistry and polymers |
# | Technology | |
---|---|---|
#1 | Acyclic or carbocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Foods | |
#5 | Special foods | |
#6 | Special acyclic compounds | |
#7 | Peptides | |
#8 | Candles | |
#9 | Heterocyclic compounds | |
#10 | Special macromolecular compounds |
# | Name | Total Patents |
---|---|---|
#1 | Sciavolino Frank C | 53 |
#2 | Mathias Gary | 30 |
#3 | Mylari Banavara L | 30 |
#4 | Van Zandt Michael C | 13 |
#5 | Dworak Jessica J | 13 |
#6 | Jagdmann Gunnar Erik Jr | 7 |
#7 | Jagdmann Jr Gunnar Erik | 4 |
#8 | Frank C Sciavolino | 3 |
#9 | Jagdmann Gunnar Erik | 2 |
#10 | Gary Mathias | 2 |
Publication | Filing date | Title |
---|---|---|
CN109562186A | Composition related with the salt of special rush recession medium of inflammation and method | |
US2017119841A1 | Amino acid salts of unsaturated fatty acids | |
WO2017079391A1 | Amino acid salts of saturated fatty acids | |
US2016199385A1 | Mineral amino-acid complexes of active agents | |
US2016107985A1 | Compositions and methods relating to ionic salts of peptides | |
US2015366980A1 | Mineral amino-acid complexes of fatty acids | |
US2014148464A1 | Salt forms of fatty acids for the treatment of dry eye | |
WO2014011895A2 | High solubility acid salts, intravenous dosage forms, nutrition supplementation and methods of use thereof | |
AU2013290168A1 | Tri-salt form of metformin | |
US2015197475A1 | Tri-salt form of metformin | |
WO2014008374A2 | Combination therapies comprising metformin salts and antihyperglycemia agents or antihyperlipidemia agents | |
WO2014008379A2 | Diamine and meglumine salt forms of fatty acids | |
US2014018419A1 | Tri-salt form of metformin |